Contact

Posts tagged 'TL Nanoparticles'

TL Mobile “On-Demand” Manufacturing of mRNA Vaccines
TL Exosomes Advance from Biological Curiosities to Preclinical Applications
TL Lyophilized mRNA Vaccines Advance to Clinical Trials
TL Combating HIV/AIDS with mRNA Vaccines and CRISPR Gene Editing
TL It’s Prime Time for mRNA in Cancer Immunotherapy Research
TL Spotlight on Women and Girls in Science
TL Applying CleanCap® mRNA: 4 Example Studies
Loading...
58 view(s)

TL Applying CleanCap® mRNA: 4 Example Studies

Historically, reporter genes have been delivered as DNA plasmids for transcription into mRNA before translation into a reporter protein. In biological systems, ideal reporter proteins generate highly sensitive signals that are easily measurable. Thus, they are often photoluminescent (e.g., GFP) or chemiluminescent (e.g., luciferase).

TL Four Pillars for Successful Self-Amplifying RNA Vaccines…
Loading...
596 view(s)

TL Four Pillars for Successful Self-Amplifying RNA Vaccines…

The current universe of vaccines can be divided into two main categories, conventional vaccines and nucleic acid vaccines (Blakney et al.). Conventional vaccines are based on a protein adjuvant, and nucleic acid vaccines can be based on DNA or RNA. For this blog, we will focus on nucleic acid vaccines based on RNA structures and, in particular, self-amplifying RNA vaccines (Figure 1).

TL CleanCap® IVT Cas9 mRNA in Micelles Used for Genome Editing in Mouse Brain for the First Time
Loading...
54 view(s)

TL CleanCap® IVT Cas9 mRNA in Micelles Used for Genome Editing in Mouse Brain for the First Time

CRISPR-based genome editing tools show tremendous potential as therapeutic agents for the treatment of genetic diseases and viral infections, as discussed in previous Zone blogs and the June 2021 TriLink Research Spotlight titled, A Novel Base-Editing Strategy Promises to Treat Sickle Cell Disease. Nevertheless, safe and efficient delivery of CRISPR tools to target tissues continues to attract growing attention (see Chart). A wide variety of technical approaches are being explored, the main one being the formulation of nano-sized particles loaded with different types of CRISPR-related cargo.